News //  

News //  

News //  

News //  

News //  

News //  

News //  

News //  

News //  

Jellatech Achieves Milestone: Delivers First Human Type I Collagen Samples

[January 21, 2024, Morrisville, NC] – Jellatech, a leading biotechnology company revolutionizing the production of bio-identical human collagen through cellular agriculture, is thrilled to announce the successful delivery of its first human Type I collagen sample in December 2024, followed by a second delivery in January 2025. This marks a significant milestone in the company’s mission to provide a consistent, scalable, and ethical supply of high-quality collagen for biomedical applications.

With more samples now available on a monthly basis, Jellatech is accelerating the adoption of human Type I collagen for a wide range of applications, including regenerative medicine, medical aesthetics, tissue engineering, and therapeutic solutions.

“These first deliveries demonstrate the scalability and reliability of our technology,” said Stephanie Michelsen, CEO of Jellatech. “Collagen is a cornerstone biomolecule in healthcare and science, but access to fully functional, human-derived collagen has been a major barrier. Our platform not only addresses this challenge but also sets a new standard for sustainability and ethical sourcing.”

Key Applications and Benefits of Jellatech’s Collagen Platform:

  • Regenerative Medicine: Supports tissue regeneration, wound healing, and advancements in organ bioprinting.
  • Medical Aesthetics: Offers a sustainable alternative for injectables and dermal fillers, with enhanced integration and durability.
  • Therapeutics: Opens new possibilities for drug delivery systems and cell and gene therapy solutions.

Jellatech’s technology utilizes cellular agriculture to produce bio-identical human collagen without relying on animal-derived or donor-sourced materials. By replicating the body’s natural processes, the company delivers a collagen supply that is consistent, reliable, and scalable.

With ongoing sample production and deliveries, Jellatech invites partners in the biomedical and biotechnology sectors to collaborate in unlocking the full potential of human collagen for transformative healthcare solutions.

For inquiries about samples or collaborations, please contact Jellatech at hello@jellatech.com.